amifampridine has been researched along with ANS (Autonomic Nervous System) Diseases in 1 studies
Amifampridine: 4-Aminopyridine derivative that acts as a POTASSIUM CHANNEL blocker to increase release of ACETYLCHOLINE from nerve terminals. It is used in the treatment of CONGENITAL MYASTHENIC SYNDROMES.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Botulism is another rare disorder of presynaptic neuromuscular transmission that is most commonly associated with improper storage or preservation of food products." | 2.82 | Lambert-Eaton Myasthenic Syndrome and Botulism. ( Raja, SM, 2022) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Raja, SM | 1 |
1 review available for amifampridine and ANS (Autonomic Nervous System) Diseases
| Article | Year |
|---|---|
Lambert-Eaton Myasthenic Syndrome and Botulism.
Topics: Amifampridine; Autonomic Nervous System Diseases; Botulism; Humans; Lambert-Eaton Myasthenic Syndrom | 2022 |